|
1
|
Shi W, Yang J, Li S, Shan X, Liu X, Hua H,
Zhao C, Feng Z, Cai Z, Zhang L and Zhou D: Potential involvement of
miR-375 in the premalignant progression of oral squamous cell
carcinoma mediated via transcription factor KLF5. Oncotarget.
6:40172–401785. 2015.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Zini A, Czerninski R and Sgan-Cohen HD:
Oral cancer over four decades: Epidemiology, trends, histology, and
survival by anatomical sites. J Oral Pathol Med. 39:299–305.
2010.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Wang Q, Gao P, Wang X and Duan Y: The
early diagnosis and monitoring of squamous cell carcinoma via
saliva metabolomics. Sci Rep. 4(6802)2014.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Omura K: Current status of oral cancer
treatment strategies: Surgical treatments for oral squamous cell
carcinoma. Int J Clin Oncol. 19:423–430. 2014.PubMed/NCBI View Article : Google Scholar
|
|
5
|
D'Souza G and Robbins HA: Sexual and
relationship health among survivors of oropharyngeal or oral cavity
squamous cell carcinoma. Cancer. 123:1092–1094. 2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Forastiere A, Koch W, Trotti A and
Sidransky D: Head and neck cancer. N Engl J Med. 345:1890–1900.
2001.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Jadhav KB and Gupta N: Clinicopathological
prognostic implicators of oral squamous cell carcinoma: Need to
understand and revise. N Am J Med Sci. 5:671–679. 2013.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Zhao S, Yan L, Zhao Z and Rong F:
Up-regulation of miR-203 inhibits the growth of cervical cancer
cells by inducing cell cycle arrest and apoptosis. Eur J
Gynaecological Oncol. 40:791–795. 2019.
|
|
9
|
Karamitopoulou E, Haemmig S, Baumgartner
U, Schlup C, Wartenberg M and Vassella E: MicroRNA dysregulation in
the tumor microenvironment influences the phenotype of pancreatic
cancer. Mod Pathol. 30:1116–1125. 2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Paliouras AR, Monteverde T and Garofalo M:
Oncogene-induced regulation of microRNA expression: Implications
for cancer initiation, progression and therapy. Cancer Lett.
421:152–160. 2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Ganci F, Sacconi A, Manciocco V, Covello
R, Benevolo M, Rollo F, Strano S, Valsoni S, Bicciato S, Spriano G,
et al: Altered peritumoral microRNA expression predicts head and
neck cancer patients with a high risk of recurrence. Mod Pathol.
30:1387–1401. 2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Katz B, Trope CG, Reich R and Davidson B:
MicroRNAs in ovarian cancer. Hum Pathol. 46:1245–1256.
2015.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Szabó Z, Szegedi K, Gombos K, Mahua C,
Flasko T, Harda K and Halmos G: Expression of miRNA-21 and
miRNA-221 in clear cell renal cell carcinoma (ccRCC) and their
possible role in the development of ccRCC. Urol Oncol.
34:533.e21–533.e27. 2016.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Zhao J, Dong X, Liu QC and Lu Q:
Expression of plasma miR-106a in epithelial ovarian cancer and its
diagnostic and prognostic significance. Eur J Gynaecol Oncol.
39:769–772. 2018.
|
|
15
|
Wu Y, Sun X, Song B, Qiu X and Zhao J:
miR-375/SLC7A11 axis regulates oral squamous cell carcinoma
proliferation and invasion. Cancer Med. 6:1686–1697.
2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Cao ZH, Cheng JL, Zhang Y, Bo CX and Li
YL: MicroRNA-375 inhibits oral squamous cell carcinoma cell
migration and invasion by targeting platelet-derived growth
factor-A. Mol Med Rep. 15:922–928. 2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Dong J, Geng J and Tan W: miR-363-3p
suppresses tumor growth and metastasis of colorectal cancer via
targeting SphK2. Biomed Pharmacother. 105:922–931. 2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Wang Y, Chen T, Huang H, Jiang Y, Yang L,
Lin Z, He H, Liu T, Wu B, Chen J, et al: miR-363-3p inhibits tumor
growth by targeting PCNA in lung adenocarcinoma. Oncotarget.
8:20133–20144. 2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Hu F, Min J, Cao X, Liu L, Ge Z, Hu J and
Li X: miR-363-3p inhibits the epithelial-to-mesenchymal transition
and suppresses metastasis in colorectal cancer by targeting Sox4.
Biochem Biophys Res Commun. 474:35–42. 2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Chang J, Gao F, Chu H, Lou L, Wang H and
Chen Y: miR-363-3p inhibits migration, invasion, and
epithelial-mesenchymal transition by targeting NEDD9 and SOX4 in
non-small-cell lung cancer. J Cell Physiol. 235:1808–1820.
2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Inokuchi J, Komiya M, Baba I, Naito S,
Sasazuki T and Shirasawa S: Deregulated expression of KRAP, a novel
gene encoding actin-interacting protein, in human colon cancer
cells. J Hum Genet. 49:46–52. 2004.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Kakiuchi S, Daigo Y, Tsunoda T, Yano S,
Sone S and Nakamura Y: Genome-wide analysis of organ-preferential
metastasis of human small cell lung cancer in mice. Mol Canaer Res.
1:485–499. 2003.PubMed/NCBI
|
|
23
|
Lin Z, Crockett DK, Jenson SD, Lim MS and
Elenitoba-Johnson KSJ: Quantitative proteomic and transcriptional
analysis of the response to the p38 mitogen-activated protein
kinase inhibitor SB203580 in transformed follicular lymphoma cells.
Mol Cell Proteomics. 3:820–833. 2004.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Min BM, Woo KM, Lee G and Park NH:
Terminal differentiation of normal human oral keratinocytes is
associated with enhanced cellular TGF-beta and phospholipase
C-gamma 1 levels and apoptotic cell death. Exp Cell Res.
249:377–385. 1999.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Li L, Zhu X, Shou T, Yang L, Cheng X, Wang
J, Deng L and Zheng Y: MicroRNA-28 promotes cell proliferation and
invasion in gastric cancer via the PTEN/PI3K/AKT signalling
pathway. Mol Med Rep. 17:4003–4010. 2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Lal A, Thomas MP, Altschuler G, Navarro F,
O'Day E, Li XL, Concepcion C, Han YC, Thiery J, Rajani DK, et al:
Capture of microRNA-bound mRNAs identifies the tumor suppressor
miR-34a as a regulator of growth factor signaling. PLoS Genet.
7(e1002363)2011.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Fu S, Chen HH, Cheng P, Zhang CB and Wu Y:
miR-155 regulates oral squamous cell carcinoma Tca8113 cell
proliferation, cycle, and apoptosis via regulating p27Kip1. Eur Rev
Med Pharmacol Sci. 21:937–944. 2017.PubMed/NCBI
|
|
29
|
Rastogi B, Kumar A, Raut SK, Panda NK,
Rattan V, Joshi N and Khullar M: Downregulation of miR-377 promotes
oral squamous cell carcinoma growth and migration by targeting
HDAC9. Cancer Invest. 35:152–162. 2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Lu YC, Cheng AJ, Lee LY, You GR, Li YL,
Chen HY and Chang JT: miR-520b as a novel molecular target for
suppressing stemness phenotype of head-neck cancer by inhibiting
CD44. Sci Rep. 7(2042)2017.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Zhu A, Li X, Wu H, Miao Z, Yuan F, Zhang
F, Wang B and Zhou Y: Molecular mechanism of SSFA2 deletion
inhibiting cell proliferation and promoting cell apoptosis in
glioma. Pathol Res Pract. 215:600–606. 2019.PubMed/NCBI View Article : Google Scholar
|
